This post was originally published on this site

[unable to retrieve full-text content]Infertility technology developer,  (OTCQB:INVO) has priced its public offering of 3.625M common shares at $3.20/share, for expected gross proceeds of ~$11.6M.Underwriters’ over-allotment is an …